Skip to content
Gene therapy - Lentiviral production

Gene therapy - Lentiviral production

OXGENE helps solve the challenge of scalable manufacture for gene therapy. We have redeveloped the lentiviral plasmid system, resulting in yields greater than 1×10⁸ TU/ml. We have also generated manufacture-ready, suspension-mode lentiviral packaging cell lines to facilitate large scale lentiviral production.

Our technologies maximise process reproducibility and minimise manufacturing costs for some of the industry’s most exciting therapies.

Download this resource to read on...

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.

Our single technology platform that fully connects our smart labs with our customer service proposition.

Login

Connex revolutionises DNA design, optimization and assembly by ensuring the highest levels of qualify control, efficiency and project management available for any client.

OXGENE has fully integrated all its smart labs and robotic production processes within a single technology platform that allows real-time project updates for our customers.